Загрузка...
Current status of bevacizumab in advanced ovarian cancer
Ovarian cancer is the most lethal gynecological cancer, mainly because of the delay in diagnosis. Recently, much effort has been put into investigating and introducing novel targeted agents into clinical practice, with the aim of improving prognosis and quality of life. Angiogenesis is a possible ta...
Сохранить в:
| Главные авторы: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3724566/ https://ncbi.nlm.nih.gov/pubmed/23901283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S46301 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|